The market is up 1.0% over the last week and has seen a remarkable 28% increase over the past 12 months, with earnings expected to grow by 15% per annum in the coming years. In this robust environment, identifying undiscovered gems can provide significant opportunities for investors looking to capitalize on emerging growth potential.
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
Morris State Bancshares | 10.20% | -0.28% | 6.97% | ★★★★★★ |
Teekay | NA | -6.48% | 55.79% | ★★★★★★ |
Mission Bancorp | 25.37% | 16.23% | 20.16% | ★★★★★★ |
Omega Flex | NA | 1.31% | 3.88% | ★★★★★★ |
First Northern Community Bancorp | NA | 7.12% | 10.04% | ★★★★★★ |
Banco Latinoamericano de Comercio Exterior S. A | 311.64% | 21.07% | 24.77% | ★★★★★☆ |
Innovex International | 19.92% | 29.88% | 40.68% | ★★★★★☆ |
San Juan Basin Royalty Trust | NA | 33.61% | 35.00% | ★★★★★☆ |
Valhi | 38.71% | 2.57% | -19.76% | ★★★★★☆ |
FRMO | 0.17% | 12.99% | 23.62% | ★★★★☆☆ |
Click here to see the full list of 209 stocks from our US Undiscovered Gems With Strong Fundamentals screener.
Let's dive into some prime choices out of from the screener.
Simply Wall St Value Rating: ★★★★★★
Overview: Viemed Healthcare, Inc., along with its subsidiaries, offers home medical equipment and post-acute respiratory healthcare services to patients in the United States and has a market cap of $295.08 million.
Operations: Viemed Healthcare generates revenue primarily from its Sleep and Respiratory Disorders Sector, amounting to $205.70 million.
Viemed Healthcare has shown robust performance with earnings growing 29% last year, outpacing the healthcare industry’s 6%. The company boasts a satisfactory net debt to equity ratio of 0.6%, and its interest payments are well covered by EBIT at 19x. Despite a dip in Q2 net income to US$1.47 million from US$2.33 million, revenue guidance for Q3 is promising at around US$56.5-57.7 million, indicating potential continued growth.
Gain insights into Viemed Healthcare's historical performance by reviewing our past performance report.
Simply Wall St Value Rating: ★★★★★★
Overview: Gatos Silver, Inc. is involved in the exploration, development, and production of precious metals with a market cap of $1.06 billion (NYSE:GATO).
Operations: Gatos Silver, Inc. generates its revenue primarily from the exploration, development, and production of precious metals. The company has a market cap of $1.06 billion (NYSE:GATO).
Gatos Silver has seen impressive earnings growth of 397.4% over the past year, outpacing the Metals and Mining industry’s -23%. The company is debt-free and reported net income of US$9.16 million for Q2 2024, a significant improvement from a net loss of US$3.59 million a year ago. Recently, First Majestic Silver Corp announced plans to acquire Gatos for approximately US$950 million, valuing each Gatos share at $13.49 based on current prices.
Review our historical performance report to gain insights into Gatos Silver's's past performance.
Simply Wall St Value Rating: ★★★★★☆
Overview: Innovex International, Inc. designs, manufactures, installs, rents, and sells a suite of well-centric engineered products to oil and gas industries worldwide with a market cap of $1.07 billion.
Operations: Innovex International generates revenue primarily from its oil well equipment and services segment, amounting to $550.34 million. The company's market cap stands at $1.07 billion.
Innovex International, a small player in the energy services sector, has shown impressive earnings growth of 40.7% over the past year, outpacing the industry average of 12.9%. Their debt situation appears manageable with an interest coverage ratio of 14.8x EBIT and a net debt to equity ratio at 14.3%. Despite trading at nearly 95% below its estimated fair value, recent financials indicate some challenges; for instance, second-quarter sales dropped to US$130.3 million from US$147.64 million last year while net income fell to US$9.53 million from US$20.59 million during the same period.
Learn about Innovex International's historical performance.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NasdaqCM:VMD NYSE:GATO and NYSE:INVX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.